May 07, 2026

Psilocybin for Cocaine Use: Signal or Noise?

Pilot randomized study suggests possible benefit, but blinding concerns and limited generalizability complicate interpretation

Conexiant

May 07, 2026

Do Head Hits Shift the Gut Microbiome?

A small observational study in collegiate football players found microbiome associations after nonconcussive head impacts, though findings were limited by severe underpowering and high attrition

Conexiant

May 07, 2026

Physician Exit Intent Declined, Workforce Risks Persist

Workflow inefficiency, staffing shortages, compensation, and EHR burden remained leading concerns among physicians considering reducing clinical work or leaving their organizations.

Conexiant

May 06, 2026

Side Effects: Progress, with Asterisks

Burnout is easing. Sleep science is getting weird. And dental schools have been winging cadaver training for 50 years. This week's research is full of good news that immediately complicates itself.

Conexiant

May 06, 2026

Bereavement Tied to Higher Cardiovascular Risk

Acute post-loss period and pandemic conditions each amplified cardiovascular vulnerability in nationwide Swedish cohort study

Conexiant

May 06, 2026

Invasive NSTEMI Strategy Shows No Benefit in Frail Patients

Frailty severity may identify older patients least likely to benefit—and potentially at higher risk—with invasive management

Conexiant

May 06, 2026

Semaglutide Tested in Alcohol Use Disorder

Randomized trial found improvements in alcohol consumption and metabolic outcomes, with gastrointestinal adverse events more common with treatment

Conexiant

May 05, 2026

Low Follow-Up After Behavioral ED Care

Follow-up occurred after fewer than 15% of mental health ED visits and about 11% of substance use–related visits in Washington Medicaid claims.

Conexiant

May 05, 2026

AI Platform Linked to Modest Anxiety Improvements

Randomized trial shows small symptom reductions vs group therapy and control, with outcomes shaped by worsening scores in comparator arms

Conexiant

May 05, 2026

Prescribing Outside the Exam Room

A DEA case exposes how controlled substances can move outside clinical oversight.

Conexiant